ORAL TYPHOID VACCINE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Name: Oral Typhoid Vaccine Market News
Creator: Coherent Market Insights
License: https://www.coherentmarketinsights.com/privacy-policy
Keywords: Oral Typhoid Vaccine Market, Oral Typhoid Vaccine Market Size, Oral Typhoid Vaccine Market Share, Oral Typhoid Vaccine Market Analysis, Oral Typhoid Vaccine Market Trends, Oral Typhoid Vaccine Market Report, Oral Typhoid Vaccine Market Research, Oral Typhoid Vaccine Industry, Oral Typhoid Vaccine Industry Report

Oral Typhoid Vaccine Market, By Distribution Channel (Hospitals and Clinics, Hospital Pharmacies, Retail Pharmacie, Online Pharmacies, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East)

Published In : Dec 2023
Code : CMI6332
Pages :140
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

In March 2020, Daewoong Pharmaceutical, a South Korea-based pharmaceutical company, launched the Vivotif, an oral typhoid fever vaccine, in the local market.
In February 2023, Bavarian Nordic, a fully integrated vaccine company focused on the development, manufacturing and commercialization of life-saving vaccines, announced acquisition of typhoid fever vaccine, Vivotif, and its cholera shot, Vaxchora, alongside the late-stage chikungunya candidate CHIKV VLP.